Sorrento Therapeutics Inc (SRNE)

7.54 +0.12  +1.62% NASDAQ Apr 21, 13:02 USD
View Full Chart
Price Chart
View All SRNE News

News

View All Events

Events

Date Type Description
10/16/2020 12:00 PDT Agm 2019 Annual General Meeting
11/09/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/09/2021 00:00 Earnings Results Q3 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.
  • URL: https://www.sorrentotherapeutics.com
  • Investor Relations URL: https://sorrentotherapeutics.com/investors/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 09, 2021
  • Last Earnings Release: Nov. 09, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
ASUIX Arabesque Systematic USA Institutional 2.18%
GNOM Global X Genomics & Biotechnology ETF 1.94%
IWC iShares Micro-Cap ETF 0.38%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.